Does CABOZANTINIB S-MALATE Cause Platelet count decreased? 443 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 443 reports of Platelet count decreased have been filed in association with CABOZANTINIB S-MALATE (CABOMETYX). This represents 1.1% of all adverse event reports for CABOZANTINIB S-MALATE.
443
Reports of Platelet count decreased with CABOZANTINIB S-MALATE
1.1%
of all CABOZANTINIB S-MALATE reports
28
Deaths
91
Hospitalizations
How Dangerous Is Platelet count decreased From CABOZANTINIB S-MALATE?
Of the 443 reports, 28 (6.3%) resulted in death, 91 (20.5%) required hospitalization, and 4 (0.9%) were considered life-threatening.
Is Platelet count decreased Listed in the Official Label?
Yes, Platelet count decreased is listed as a known adverse reaction in the official FDA drug label for CABOZANTINIB S-MALATE.
What Other Side Effects Does CABOZANTINIB S-MALATE Cause?
Diarrhoea (8,282)
Fatigue (6,819)
Off label use (5,245)
Nausea (4,341)
Decreased appetite (4,076)
Blood pressure increased (2,939)
Malignant neoplasm progression (2,718)
Palmar-plantar erythrodysaesthesia syndrome (2,706)
Weight decreased (2,657)
Stomatitis (2,560)
What Other Drugs Cause Platelet count decreased?
LENALIDOMIDE (7,491)
NIRAPARIB (4,102)
ELTROMBOPAG OLAMINE (3,419)
RUXOLITINIB (3,028)
RITUXIMAB (2,404)
VENETOCLAX (2,367)
DEXAMETHASONE (2,321)
PALBOCICLIB (2,277)
CYCLOPHOSPHAMIDE (1,894)
RIBAVIRIN (1,701)
Which CABOZANTINIB S-MALATE Alternatives Have Lower Platelet count decreased Risk?
CABOZANTINIB S-MALATE vs CAFFEINE
CABOZANTINIB S-MALATE vs CALASPARGASE PEGOL
CABOZANTINIB S-MALATE vs CALASPARGASE PEGOL-MKNL
CABOZANTINIB S-MALATE vs CALCIFEDIOL
CABOZANTINIB S-MALATE vs CALCIPOTRIENE